Loading the player...

# Use Youtube player (with Youtube AD) #<<<>>> # Use our player (Downlaod, Unblock & No Youtube AD) 再生できないときはここをクリック　click here if failed to load 如无法播放请点击这里#

INFO:
Dr. Jänne, Director, Lowe Center for Thoracic Oncology, Professor of Medicine, Harvard Medical School, Dana Farber Cancer Institute, discusses the incidence of EGFR exon 20 insertions in NSCLC (non-small cell lung cancer), whether these patients have worse morbidity, and if EGFR exon 20 insertions are actionable mutations.
Pasi Jänne, MD, PhD, elaborates on EGFR exon 20 insertions in non-small cell lung cancer